Comparative study of Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade - Trial PACTR201510001292136
Access comprehensive clinical trial information for PACTR201510001292136 through Pure Global AI's free database. This Not Applicable trial is sponsored by shahira el metainy and is currently Not yet recruiting. The study focuses on Respiratory; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
shahira el metainy
el Faculty of Medicine, University of Alexandria, Egypt
Timeline & Enrollment
Not Applicable
Mar 09, 2016
Jan 01, 1900
Summary
Postoperative residual paralysis remains a common occurrence following the use of neuromuscular blocking agents (NMBAs), Rapid and complete reversal of neuromuscular blockade (NMB) is desirable at the end of surgery. Sugammadex reverses rocuronium-induced NMB by encapsulation. Prompt recovery of laryngeal reflexes and spontaneous respiration at the end of the interventional bronchoscopy procedures prevent adverse respiratory eventsAim of the workThe aim of this study was to compare the efficacy of sugammadex and neostigmine on reversing neuromuscular blockade in elderly patients undergoing lung biopsy
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201510001292136
Non-Device Trial